We are live on ! Find out more
SO

STRS Ohio Portfolio holdings

AUM $25.2B
1-Year Est. Return 30.31%
This Fund
S&P 500
This Quarter Est. Return
+12.58%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$24B
AUM Growth
+$1.56B
Cap. Flow
-$931M
Cap. Flow %
-3.87%
Top 10 Hldgs %
25.33%
Holding
2,059
New
128
Increased
454
Reduced
915
Closed
153

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$36.7M
2
VICI icon
VICI Properties
VICI
+$32.5M
3
ELV icon
Elevance Health
ELV
+$27.3M
4
ACGL icon
Arch Capital
ACGL
+$24.7M
5
KRG icon
Kite Realty
KRG
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 26.86%
2 Financials 12.81%
3 Healthcare 12.06%
4 Consumer Discretionary 10.3%
5 Industrials 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLTR icon
1026
Palantir
PLTR
$315B
$739K ﹤0.01%
43,063
-7,250
-14% -$129K
NSSC icon
1027
Napco Security Technologies
NSSC
$1.3B
$736K ﹤0.01%
21,500
-5,500
-20% -$146K
OCFC icon
1028
OceanFirst Financial
OCFC
$1.7B
$734K ﹤0.01%
42,300
+800
+2% +$11.7K
VCEL icon
1029
Vericel Corp
VCEL
$2.31B
$733K ﹤0.01%
20,600
GRBK icon
1030
Green Brick Partners
GRBK
$3.12B
$732K ﹤0.01%
14,100
MDXG icon
1031
MiMedx Group
MDXG
$635M
$726K ﹤0.01%
82,800
-3,300
-4% -$24.2K
AVPT icon
1032
AvePoint
AVPT
$2.72B
$725K ﹤0.01%
88,400
+3,300
+4% +$25.8K
CDNA icon
1033
CareDx
CDNA
$1.88B
$723K ﹤0.01%
60,300
+23,800
+65% +$195K
EGBN icon
1034
Eagle Bancorp
EGBN
$858M
$723K ﹤0.01%
24,000
-3,000
-11% -$70.8K
HIMS icon
1035
Hims & Hers Health
HIMS
$7B
$723K ﹤0.01%
81,300
-20,700
-20% -$153K
NHC icon
1036
National Healthcare
NHC
$3.53B
$720K ﹤0.01%
+7,800
New +$598K
WLY icon
1037
John Wiley & Sons Class A
WLY
$2.59B
$720K ﹤0.01%
22,700
THR
1038
DELISTED
Thermon Group Holdings
THR
$719K ﹤0.01%
22,100
-3,000
-12% -$89.4K
AWR icon
1039
American States Water
AWR
$3.37B
$715K ﹤0.01%
8,900
-2,500
-22% -$200K
HY icon
1040
Hyster-Yale Materials Handling
HY
$596M
$715K ﹤0.01%
11,500
-2,200
-16% -$105K
ADUS icon
1041
Addus HomeCare
ADUS
$2.16B
$714K ﹤0.01%
7,700
-1,100
-13% -$95.6K
ARCH
1042
DELISTED
Arch Resources, Inc.
ARCH
$713K ﹤0.01%
4,300
-3,100
-42% -$487K
ALKS icon
1043
Alkermes
ALKS
$8.79B
$712K ﹤0.01%
25,700
-25,200
-50% -$655K
SHEN icon
1044
Shenandoah Telecom
SHEN
$637M
$711K ﹤0.01%
32,900
-1,000
-3% -$22.4K
NVRI icon
1045
Enviri
NVRI
$620M
$709K ﹤0.01%
78,800
-5,300
-6% -$36.1K
PRLB icon
1046
Protolabs
PRLB
$1.85B
$709K ﹤0.01%
18,200
-1,000
-5% -$32.4K
ZEUS
1047
DELISTED
Olympic Steel
ZEUS
$707K ﹤0.01%
10,600
-1,300
-11% -$71.3K
NABL icon
1048
N-able
NABL
$823M
$706K ﹤0.01%
53,300
+21,900
+70% +$278K
PLMR icon
1049
Palomar
PLMR
$3.73B
$704K ﹤0.01%
12,700
-700
-5% -$39.2K
PSMT icon
1050
Pricesmart
PSMT
$5.81B
$704K ﹤0.01%
9,300
-2,600
-22% -$185K

Similar funds

STRS Ohio's Q4 2023 Portfolio in Review

As of Q4 2023, STRS Ohio held 2,059 positions worth $24B, up 6.9% from $22.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

STRS Ohio withdrew a net $931M in Q4 2023, closing 153 positions and reducing 915 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $55.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

Against the trend, STRS Ohio opened a new position in Synovus worth $16.4M.

  • STRS Ohio's largest Q4 2023 buy was Synovus: 436,000 shares worth $16.4M.
  • STRS Ohio added most to Broadcom in Q4 2023, an estimated $36.7M increase.
  • STRS Ohio's biggest Q4 2023 reduction was Apple, cutting an estimated $48.9M.
  • STRS Ohio fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $55.4M.
  • STRS Ohio's ten largest holdings make up 25% of its $24B portfolio in Q4 2023.
  • STRS Ohio opened 128 new positions and closed 153 in Q4 2023.
  • STRS Ohio's portfolio value rose 6.9% quarter-over-quarter to $24B.

Based on STRS Ohio's 13F filing for Q4 2023, filed 30 Jan 2024.